Company Overview of Pharnext SAS
Pharnext SAS, a biopharmaceutical company, engages in the development of treatments for severe neurological diseases. The company specializes in drug repositioning. Its target pathologies include Charcot-Marie-Tooth disease; and diabetic and toxic peripheral neuropathies, as well as severe neurodegenerative diseases in general and peripheral neuropathies. The company was founded in 2007 and is based in Paris, France.
Pépinière Santé Cochin
29 rue du Faubourg Saint Jacques
Founded in 2007
33 1 55 42 62 00
33 1 55 42 62 01
Key Executives for Pharnext SAS
Pharnext SAS Key Developments
Similar Private Companies By Industry
|Carbogen Amcis SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Pharnext SAS, please visit www.pharnext.com. Company data is provided by Capital IQ. Please use this form to report any data issues.